Expert faculty members summarize key viral hepatitis studies from this important annual conference.
Listen to downloadable audio from a live Webinar in which Stefan Zeuzem, MD, assessed the clinical impact of new data reported at the Paris meeting and answered case questions from participants.
SVR12 rate of 96% in population where majority had ongoing drug use and/or were receiving opiate substitution therapy.
Among 3 patients who relapsed without achieving SVR12, all had resistance associated substitutions.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.